Predictive validity of NeoAdjuvant Rectal (NAR) Score and pathologic complete response (ypCR) for overall survival (OS) as surrogate endpoints in rectal cancer clinical trial.
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Predictive validity of NeoAdjuvant Rectal (NAR) Score and pathologic complete response (ypCR) for overall survival (OS) as surrogate endpoints in rectal cancer clinical trial. |
| Type de publication | Journal Article |
| Year of Publication | 2016 |
| Auteurs | Yothers G, George TJ, Allegra CJoseph, Bosset J-F, Bujko K, Collette L, O'Connell MJ, Doyen J, Fernandez-Martos C, Seitz JFrancois, Wolmark N |
| Journal | JOURNAL OF CLINICAL ONCOLOGY |
| Volume | 34 |
| Date Published | MAY 20 |
| Type of Article | Meeting Abstract |
| ISSN | 0732-183X |
| DOI | 10.1200/JCO.2016.34.15_suppl.3533 |